| Style | Citing Format |
|---|---|
| MLA | Skowronski J, et al.. "Dapagliflozin in Acute Heart Failure: Lessons From the Dapa Act Hf–Timi 68 Trial." Heart Failure Reviews, vol. 31, no. 1, 2026, pp. -. |
| APA | Skowronski J, Hosseini K, Bruno J, Sakata Y, Nodari S, Keramida K, Cedarbaum ER, Canonico ME, Palazzuoli A, Kato E (2026). Dapagliflozin in Acute Heart Failure: Lessons From the Dapa Act Hf–Timi 68 Trial. Heart Failure Reviews, 31(1), -. |
| Chicago | Skowronski J, Hosseini K, Bruno J, Sakata Y, Nodari S, Keramida K, Cedarbaum ER, Canonico ME, Palazzuoli A, Kato E. "Dapagliflozin in Acute Heart Failure: Lessons From the Dapa Act Hf–Timi 68 Trial." Heart Failure Reviews 31, no. 1 (2026): -. |
| Harvard | Skowronski J et al. (2026) 'Dapagliflozin in Acute Heart Failure: Lessons From the Dapa Act Hf–Timi 68 Trial', Heart Failure Reviews, 31(1), pp. -. |
| Vancouver | Skowronski J, Hosseini K, Bruno J, Sakata Y, Nodari S, Keramida K, et al.. Dapagliflozin in Acute Heart Failure: Lessons From the Dapa Act Hf–Timi 68 Trial. Heart Failure Reviews. 2026;31(1):-. |
| BibTex | @article{ author = {Skowronski J and Hosseini K and Bruno J and Sakata Y and Nodari S and Keramida K and Cedarbaum ER and Canonico ME and Palazzuoli A and Kato E}, title = {Dapagliflozin in Acute Heart Failure: Lessons From the Dapa Act Hf–Timi 68 Trial}, journal = {Heart Failure Reviews}, volume = {31}, number = {1}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Skowronski J AU - Hosseini K AU - Bruno J AU - Sakata Y AU - Nodari S AU - Keramida K AU - Cedarbaum ER AU - Canonico ME AU - Palazzuoli A AU - Kato E TI - Dapagliflozin in Acute Heart Failure: Lessons From the Dapa Act Hf–Timi 68 Trial JO - Heart Failure Reviews VL - 31 IS - 1 SP - EP - PY - 2026 ER - |